Guidance for Vertex Pharmaceuticals Incorporated (VRTX)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2026 N/A N/A $12.95B – 13.10B $13.00B = Maintained Details
2025 N/A N/A $11.90B – 12.00B $12.00B = Maintained Details
2025 N/A N/A $11.85B – 12.00B $11.94B = Maintained Details
2025 N/A N/A $11.85B – 12.00B $11.98B = Maintained Details
2025 N/A N/A $11.75B – 12.00B $11.85B = Maintained Details
2024 N/A N/A $10.80B – 10.90B $10.76B = Maintained Details
2024 N/A N/A $10.65B – 10.85B $10.76B = Maintained Details
2024 N/A N/A $10.55B – 10.75B $10.72B = Maintained Details
Q1 2024 N/A N/A $10.55B – 10.75B $10.61B = Maintained Details
2023 N/A N/A $9.85B $9.87B = Maintained Details
2023 N/A N/A $9.55B – 9.70B $9.70B = Maintained Details
Q1 2023 N/A N/A $9.55B – 9.70B $9.60B = Maintained Details
2022 N/A N/A $8.80B – 8.90B $8.77B Raised Details
2022 N/A N/A $8.60B – 8.80B $8.58B Raised Details
2022 N/A N/A $8.40B – 8.60B $8.58B = Maintained Details
2022 N/A N/A $8.40B – 8.60B $8.22B Raised Details
2021 N/A N/A $7.40B – 7.50B $7.32B Raised Details
2021 N/A N/A $7.20B – 7.40B $6.99B = Maintained Details
2021 N/A N/A $6.70B – 6.90B $6.95B = Maintained Details
2020 N/A N/A $5.70B – 5.90B $5.73B = Maintained Details
2020 N/A N/A $5.30B – 5.60B $5.33B = Maintained Details
2020 N/A N/A $5.10B – 5.30B $4.87B = Maintained Details
2019 N/A N/A $3.70B – 3.75B $3.74B = Maintained Details
2019 N/A N/A $3.60B – 3.70B $3.55B = Maintained Details
2019 N/A N/A $3.45B – 3.55B $3.56B = Maintained Details
2019 N/A N/A $3.45B – 3.55B $3.55B = Maintained Details
Q3 2018 N/A N/A N/A N/A = Maintained Details
Q2 2018 N/A N/A N/A N/A = Maintained Details
Q1 2018 N/A N/A N/A N/A = Maintained Details
2017 N/A N/A $2.10B – 2.50B $2.30B = Maintained Details
Q3 2017 N/A N/A N/A N/A = Maintained Details
Q2 2017 N/A N/A N/A N/A = Maintained Details
Q1 2017 N/A N/A N/A N/A = Maintained Details
2014 N/A N/A $570.00M – 600.00M $620.70M = Maintained Details
2013 N/A N/A $1.00M – 1.05M $1.17M Lowered Details
2013 N/A N/A $1.10B – 1.20B $1.20B Lowered Details
2013 N/A N/A $1.10B – 1.25B $1.16B = Maintained Details